You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
|
|---|---|
| Published in |
Journal of Clinical Oncology, April 2019
|
| DOI | 10.1200/jco.18.01568 |
| Pubmed ID | |
| Authors |
Joan L Walker, Mark F Brady, Lari Wenzel, Gini F Fleming, Helen Q Huang, Paul A DiSilvestro, Keiichi Fujiwara, David S Alberts, Wenxin Zheng, Krishnansu S Tewari, David E Cohn, Matthew A Powell, Linda Van Le, Susan A Davidson, Heidi J Gray, Peter G Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C Rubin, Robert S Mannel |
X Demographics
The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 15 | 26% |
| Spain | 4 | 7% |
| United Kingdom | 4 | 7% |
| France | 3 | 5% |
| Brazil | 2 | 4% |
| Finland | 2 | 4% |
| Japan | 2 | 4% |
| Canada | 1 | 2% |
| Italy | 1 | 2% |
| Other | 6 | 11% |
| Unknown | 17 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 54% |
| Scientists | 13 | 23% |
| Practitioners (doctors, other healthcare professionals) | 10 | 18% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 171 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 21 | 12% |
| Researcher | 21 | 12% |
| Student > Doctoral Student | 11 | 6% |
| Student > Ph. D. Student | 10 | 6% |
| Student > Postgraduate | 10 | 6% |
| Other | 32 | 19% |
| Unknown | 66 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 35% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Nursing and Health Professions | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Business, Management and Accounting | 4 | 2% |
| Other | 15 | 9% |
| Unknown | 75 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2019.
All research outputs
#521,937
of 25,385,509 outputs
Outputs from Journal of Clinical Oncology
#1,086
of 22,054 outputs
Outputs of similar age
#11,666
of 364,188 outputs
Outputs of similar age from Journal of Clinical Oncology
#36
of 599 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 599 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.